Lichen International Limited Announces Pricing of $3.5 Million Registered Direct Offering
Each unit includes a share or pre-funded warrant plus a warrant to purchase 4.72 Class A ordinary shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lichen International (NASDAQ: LICN) entered securities purchase agreements with institutional investors for a registered direct offering estimated to raise approximately $3.5 million gross.
The offering comprises 17,500,000 units at $0.20 each. Each unit includes one Class A ordinary share, or one pre-funded warrant instead, and one warrant to purchase 4.72 Class A ordinary shares. The warrants have a $0.20 exercise price per share, are immediately exercisable upon issuance and expire on the one-year anniversary of issuance. The company expects closing on November 11, 2026, subject to customary closing conditions. Gross proceeds exclude placement agent fees and other estimated offering expenses.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major point. Forward-looking: it has not happened yet and may not happen.Approximately $3.5 million in estimated gross proceeds would provide funding through the registered direct offering. 70% of market cap
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.17,500,000 units at $0.20 each include shares or pre-funded warrants, diluting existing holders.
- Minor point. Forward-looking: it has not happened yet and may not happen.One warrant per unit permits purchasing 4.72 shares at $0.20 each, adding potential dilution; exercisable immediately, expiring after one year.
- Minor point. Forward-looking: it has not happened yet and may not happen.Placement agent fees and other estimated offering expenses will reduce proceeds available to the company.
News Explained
If the expected closing occurs, investors receive shares or pre-funded warrants plus warrants; issuing shares and exercising warrants can increase the share count and reduce existing holders’ ownership percentages.
Details
Market move: LICN -13.11% vs previous close. $3.5M registered direct offering
On Nov 10, the day this news came out, the latest delayed price for LICN is 13.11% below the previous close. Argus tracked a trough of -43.7% from its starting point during tracking. Our momentum scanner has recorded 28 alerts for this stock so far that day. The latest delayed price is $0.27. Relative volume is exceptionally heavy at 42.0x what this stock usually trades by this time of day.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Units offered
- 17,500,000 units
- Registered direct offering
- Offering price
- $0.20 per unit
- Registered direct offering
- Estimated gross proceeds
- Approximately $3.5 million
- Before placement agent fees and other estimated offering expenses
- Shares per warrant
- 4.72 Class A ordinary shares
- Each warrant covers this number of shares
- Warrant exercise price
- $0.20 per Class A ordinary share
- Warrants immediately exercisable upon issuance
- Warrant term
- One year
- Expires on the one-year anniversary of issuance
- Expected closing
- November 11, 2026
- Subject to customary closing conditions
Previous Offering Reports
-
Announced a $3.4 million offering of shares and pre-funded warrants.
-
Announced a $3.1 million offering of shares and pre-funded warrants.
-
Announced a $2.8 million offering of shares and pre-funded warrants.
-
Announced a $2.70 million offering of shares and pre-funded warrants.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
registered direct offering financial
pre-funded warrant financial
warrant financial
shelf registration statement regulatory
form f-3 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
XIAMEN, China, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Lichen International Limited (NASDAQ: LICN) (the "Company"), a dedicated financial and taxation service provider in China, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of an aggregate of 17,500,000 units (each, a “Unit”), consisting of one Class A Ordinary Share (or one pre-funded warrant in lieu thereof) and one warrant to purchase 4.72 Class A Ordinary Shares (each, a “Warrant”), at an offering price of
The gross proceeds to the Company from the registered direct offering are estimated to be approximately
Univest Securities, LLC is acting as the sole placement agent.
The registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-291878) previously filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) and became effective on December 10, 2025. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Univest Securities, LLC at info@univest.us, or by calling +1 (212) 343-8888.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying base prospectus will be filed by the Company and, upon filing, can be obtained at the SEC's website at www.sec.gov.
About Lichen International Limited
Lichen International Limited focuses on providing (i) financial and taxation solution services; (ii) education support services; (iii) software and maintenance services and (iv) Pre-IPO advisory services in the PRC under our "Lichen" brand. In recognition of the Company's expertise and experience in the financial and taxation solution services industry for over 20 years, the Company has built up its reputation as a dedicated financial and taxation solution services provider of professional and high-quality services in China. For more information, please visit the Company's website: https://ir.lichenzx.com/
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.
For investor and media inquiries, please contact:
LICHEN INTERNATIONAL LIMITED
Tian Sun
Phone: +86-592-5586999
Email: ir@lichenzx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the terms of Lichen International's LICN registered direct offering?
Lichen is selling 17,500,000 units at $0.20 per unit for estimated gross proceeds of approximately $3.5 million. Each unit contains one Class A ordinary share or one pre-funded warrant, plus one warrant to purchase 4.72 Class A ordinary shares at $0.20 per share.
When is Lichen International's registered direct offering expected to close?
The company expects the offering to close on November 11, 2026, subject to satisfaction of customary closing conditions.